# Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex

> **NCT02401841** · — · UNKNOWN · sponsor: **Policlinico Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Resolution of Neuromuscular Blockade

## Interventions

- **DRUG:** Two different types of drug for resolution of neuro-muscular blockade

## Key facts

- **NCT ID:** NCT02401841
- **Lead sponsor:** Policlinico Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-03
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401841, "Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02401841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
